Daejeon, South Korea

Hong Woo Kim

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 8.4

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Youseong-ku, KR (1996)
  • Daejeon, KR (1996 - 2023)

Company Filing History:


Years Active: 1996-2023

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **The Innovative Journey of Hong Woo Kim in Cancer Research**

Introduction

Hong Woo Kim, an accomplished inventor based in Daejeon, South Korea, is known for his significant contributions to cancer research through innovative pharmaceutical compositions. With a portfolio of eight patents, his work primarily focuses on guanidine compounds and their applications in inhibiting cancer cell proliferation and metastasis.

Latest Patents

Among his significant recent patents is the development of a **Biguanide compound and its use**, which pertains to a guanidine derivative that effectively inhibits cancer cell proliferation, metastasis, and recurrence. This invention promises to enhance cancer treatment by achieving remarkable results even with lower doses, making it a potential game-changer for the treatment and prevention of various cancers, including uterine, breast, stomach, and lung cancers.

Another noteworthy patent is centered around **Guanidine compounds and their use**, which involves the inhibition of mitochondrial oxidative phosphorylation (OXPHOS). This innovation focuses on a pharmaceutical composition aimed at preventing or treating OXPHOS-related diseases, particularly cancers, by reprogramming cellular metabolism, showcasing Kim’s innovative approach to tackling challenging health issues.

Career Highlights

Throughout his career, Hong Woo Kim has been associated with notable companies such as Immunomet Therapeutics Inc. and Lucky Limited. His work in these organizations has allowed him to push the boundaries of existing cancer therapies, fostering a collaborative environment for innovation and discovery.

Collaborations

Collaboration plays a vital role in Kim's journey, having worked closely with esteemed colleagues like Sung Wuk Kim and Ji Sun Lee. These partnerships have not only enriched his work but have also contributed to the broader field of cancer research, aligning their expertise towards shared goals of improving patient outcomes.

Conclusion

In conclusion, Hong Woo Kim represents a beacon of innovation in cancer research. His patents and collaborations reflect a deep commitment to developing effective treatments for various cancers. As he continues to explore the potential of guanidine compounds, the medical community eagerly anticipates the impact of his groundbreaking work on the future of oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…